Johnson & Johnson

Johnson & Johnson

Verified
Research and development, manufacture and sale of a range of products in the healthcare field

Financials

Edit
Revenues, earnings & profits over time
USD2016201720182019202020212022E
Revenues-76.5b81.6b82.1b82.6b94.1b97.4b
% growth--7 %1 %1 %14 %4 %
EBITDA--28.1b27.9b27.2b33.1b35.7b
% EBITDA margin--34 %34 %33 %35 %37 %
Profit--15.3b15.1b14.7b22.8b23.5b
% profit margin--19 %18 %18 %24 %24 %
R&D budget9.5b9.7b10.4b11.1b---
R&D % of revenue-13 %13 %14 %---

Source: Company fillings or news article

  • Edit

Recent News about Johnson & Johnson

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
  • Edit
Omrix Biopharmaceuticals
ACQUISITION by Johnson & Johnson Nov 2008
OrthoSpace
ACQUISITION by Stryker Mar 2019
Momenta Pharmaceuticals
ACQUISITION by Johnson & Johnson Aug 2020
Zarbee's
ACQUISITION by Johnson & Johnson Jul 2018
Novira Therapeutics
ACQUISITION by Johnson & Johnson Nov 2015
Inivata
ACQUISITION by NeoGenomics Laboratories May 2021
View 110 more